EFFICACY OF REMOTE MONITORING OF PATIENTS WITH DIABETES UNDER INSULIN TREATMENT, BY USING Caaring SOFTWARE

Inclusion Criteria:

• Patients with diabetes mellitus treated with insulin.

• Patients treated with subcutaneous insulin in multiple daily doses or patientstreated with subcutaneous insulin in continuous subcutaneous infusion systems

• Patients using a glucose monitoring system

• Patients who are able to complete the study questionnaires

• Informed consent is obtained from the patient.

• For Control group: Patients must have clinical and glucometry data from the 12 weeksprior to their inclusion date available in the Medical Record, and/or through themonitoring platforms of the continuous glucose monitoring devices - For Caaringgroup: Patients must have sufficient technological skills to use a smartphone.

Exclusion Criteria:

• Patients with cognitive or sensory difficulties or with insufficient command ofSpanish who, in the opinion of the investigator, makes it difficult to understandthe questions or the scales, as long as they do not have a legally authorizedrepresentative capable of participating in the study.

• Transient patients in whom it may be anticipated that follow-up will not becompleted due to a change of residence.

• Patients Who are participating at the time of recruitment in any other clinicaltrial. Participation in observational studies will not be an exclusion criteria.

• Patients whose main diagnosis is a poorly controlled mental disorders or othermedical illness.

• Patients with terminal illness and/or in palliative care according to the criteriaof the SECPAL (Spanish Society of Palliative Care).

• Institutionalized patients

• Patients who are pregnant or breastfeeding.

• Patients whose inclusion is not considered advisable by the investigator'sassessment due to they are under specific follow-up in other hospital units (hemodialysis, transplants, etc.) that require mandatory hospital attendance lessfrequently than once every two months.